Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07596368

THE EFFECT OF MOTIVATIONAL INTERVIEWING ON MENOPAUSE MYTHS AND POSTTRAUMATIC GROWTH IN POSTMENOPAUSAL WOMEN:RANDOMIZED CONTROLLED STUDY

This randomized controlled study aims to evaluate the effect of motivational interviewing on menopause myths and posttraumatic growth in postmenopausal women. Participants will be randomly assigned to an intervention group receiving four weekly motivational interviewing sessions or a control group receiving usual care. Outcomes will be assessed before and after the intervention using validated scales.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

About this study

Menopause is a biological transition that may affect women physically, psychologically, and socially. Misconceptions regarding menopause may negatively influence adaptation to this period, while positive coping may support posttraumatic growth.

Motivational interviewing is a client-centered counseling approach designed to strengthen intrinsic motivation and promote positive behavioral change. This randomized controlled trial aims to determine the effect of motivational interviewing on menopause myths and posttraumatic growth in postmenopausal women.

The study will be conducted in Family Health Centers in Gaziantep, Turkey, with 96 postmenopausal women randomly assigned to intervention and control groups. The intervention group will receive four weekly face-to-face motivational interviewing sessions lasting 30-45 minutes. The control group will receive usual care without intervention.

Data will be collected at baseline and after intervention using the Menopause Myths Scale and the Posttraumatic Growth Scale.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Women who have had their last menstrual period between 12 and 36 months ago,
  • are literate,
  • can read and write in Turkish,
  • do not have any problems that may hinder communication, and
  • do not have any diagnosed psychiatric illness will be included in the study.

Exclusion criteria

  • Those receiving HRT treatment,
  • Those whose last menstrual period was 36 months or more ago,
  • Women receiving oncology treatment.

Treatment and study plan

Motivational Interviewing

Behavioral

The researcher provided training on motivational interviewing techniques to be applied to the experimental group prior to the intervention. Women will be informed about the research, and those wishing to participate will be given a voluntary information form to read, and their verbal and written consent will be obtained. The client will be informed about the duration, number, and timing of the interviews before the start of the MG sessions. Each motivational interview session with the women in the experimental group is planned to last approximately 30-45 minutes. A total of four MG sessions will be conducted with the women in the experimental group, once a week. All sessions will be conducted by inviting the women to their family physician's office. During the MG sessions, counseling will be provided on topics related to the menopausal period in order to change the women's negative beliefs about menopause myths and to increase their post-traumatic growth levels after menopause.

Primary outcomes

  1. MENOPAUSE MYTHS SCALE

    Time frame: At the beginning and at the end of the 4-week intervention period

    Women's perceptions of menopause were measured using the Menopause Myths Scale.

Secondary outcomes

  1. Post-Traumatic Growth Scale

    Time frame: At the beginning and at the end of the 4-week intervention period

    The Post-Traumatic Growth Scale was used to assess the extent to which menopause creates trauma in women's lives.

Sponsors and collaborators

Lead sponsor

Inonu University

Other

Registry information

Important dates

Study start
2026
Primary completion
2026
Study completion
2026
First posted
May 19, 2026
Registry last updated
May 19, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.